glp-1 pipeline news 2.0: Where the Next Wave of Value Will Be Created GLP-1 Market: The Pipeline Expands

Tirzepatide is a dual action GLP-1 and GIP receptor agonist

Increasing scientific data on the obesity-pancreatic diseases conundrum also necessitates the need for integrating obesity-related markers into risk stratification and prognostic models, as well as exploring targeted therapeutic strategies in obesity-associated pancreatic disease.

Although these mechanisms have been exploited to facilitate weight loss, these medications have also been indicated for patients with cardiovascular or renal diseases, all of which have caused a recent drastic rise in prescribing GLP-1 RAs

GLP-1 (glucagon-like peptide-1) medications are a class of drugs used to treat type 2 diabetes and obesity

An expert reviews the research on weight and dermatology.

If you recently started Wegovy, you may notice slower digestion